Latest news
Moleculin reports promising preliminary phase II/III data for leukaemia drug Annamycin - Indian Pharma PostIndian Pharma Post · Tue, 04 Aug 2026 13:56:06 GMTMoleculin Biotech Reports Positive Pivotal Phase 2/3 Trial Results for Annamycin in AML - theindianpractitioner.comtheindianpractitioner.com · Mon, 03 Aug 2026 12:46:33 GMTMoleculin Biotech, Inc. SEC Filing (Aug 3, 2026) - Stock TitanStock Titan · Mon, 03 Aug 2026 10:13:46 GMTMoleculin Biotech Highlights Promising MIRACLE Trial Remission Data - TipRanksTipRanks · Fri, 31 Jul 2026 12:41:11 GMTMoleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients - globenewswire.comglobenewswire.com · Fri, 31 Jul 2026 12:10:00 GMT